Kazuaki Takabe, MD, PhD, FACS, Clinical Chief of Breast Surgery at Roswell Park Comprehensive Cancer Center shares the newest innovations of breast cancer treatment at Roswell Park and why to choose Roswell Park for your patient’s care.
Immune checkpoint inhibitor therapy, which activates T cells to kill tumor cells, is an effective way to treat some cancer types.
A research team headed by Roswell Park Comprehensive Cancer Center epidemiologist Zhihong Gong, PhD, has been awarded a five-year, $1.9 million grant from the National Cancer Institute for an investigation into the role that certain genetic ...
A Roswell Park Comprehensive Cancer Center team led by Christine Ambrosone, PhD, and Song Yao, PhD, has revealed a distinct molecular signature in the tumor tissues of Black patients with breast cancer.
Many people diagnosed with breast cancers that are small but invasive could benefit from hormone treatment, a new study led by physicians at Roswell Park Comprehensive Cancer Center confirms.
For more than a decade, the U.S. Department of Health and Human Services (HHS) has provided recommendations to Americans regarding the level and types of physical activity that have been shown to have health benefits.
Helen Cappuccino, MD, FACS, from Roswell Park Comprehensive Cancer Center discusses the high risk categories for breast cancer, why and how to screen, and how to decrease incidence.
This site is intended for healthcare professionals